Related Experiment Video
Updated: Jul 2, 2025

Skeletal Phenotype Analysis of a Conditional Stat3 Deletion Mouse Model
Published on: July 3, 2020
Crosstalk between ALK3(BMPR1A) deficiency and autophagy signaling mitigates pathological bone loss in osteoporosis
Zhixing Niu1, Yumeng Zhou2, Muchun Liang2
1State Key Laboratory of Oral Diseases, West China Hospital of Stomatology, Sichuan University, Chengdu, Sichuan, China.
Abstract:
Postmenopausal osteoporosis is recognized to be one of the major skeleton diseases strongly associated with impaired bone formation. Previous reports have indicated that the importance of bone morphogenetic protein (BMP) signaling of osteoblast lineage in bone development via classical Smad signaling, however, its critical role in osteoporosis is still not well understood. In the current study, we aim to investigate the pathological role of BMPR1A, a key receptor of BMPs, in osteoporosis and its underlying mechanism. We first found that knockdown of BMPR1A by using Col1a1-creER in osteoblasts mitigated early bone loss of osteoporosis in mice, yet along with late bone maturation defects by reducing mineral adherence rate and bone formation rate in vivo. At the cellular level, we then observed that BMPR1A deficiency promoted the proliferation of pre-osteoblasts under osteoporotic conditions but hindered their late-stage mineralization. We finally elucidated that BMPR1A deficiency compensatorily triggered mTOR-autophagy perturbation by a higher level in early osteoporotic pre-osteoblasts thus resulting in the enhancement of transient cell proliferation but impairment of final mineralization. Taken together, this study indicated the significance of BMPR1A-mTOR/autophagy axis, as a double-edged sword, in osteoporotic bone formation and provided new cues for therapeutic strategies in osteoporosis.
Insights
Bone morphogenetic protein receptor 1A (BMPR1A) plays a dual role in osteoporosis. Its deficiency initially reduces bone loss but impairs later bone maturation by affecting mTOR-autophagy pathways.
Area of Science:
- * Skeletal Biology and Disease
- * Molecular and Cellular Biology
- * Endocrinology
Background:
- * Postmenopausal osteoporosis is a major skeletal disease linked to impaired bone formation.
- * Bone morphogenetic protein (BMP) signaling is crucial for osteoblast development but its role in osteoporosis is unclear.
- * BMPR1A is a key receptor in BMP signaling pathways.
Purpose of the Study:
- * To investigate the pathological role of BMPR1A in osteoporosis.
- * To elucidate the underlying molecular mechanisms of BMPR1A's function in osteoporotic bone.
- * To explore potential therapeutic targets for osteoporosis.
Main Methods:
- * Used a Col1a1-creER mouse model to knock down BMPR1A in osteoblasts.
- * Analyzed bone loss, mineral adherence, and bone formation rates in vivo.
- * Investigated pre-osteoblast proliferation and mineralization in vitro.
- * Examined the involvement of the mTOR-autophagy pathway.
Main Results:
- * BMPR1A knockdown in osteoblasts mitigated early osteoporosis-related bone loss in mice.
- * However, BMPR1A deficiency led to defects in late bone maturation, reducing mineral adherence and bone formation rates.
- * In vitro, BMPR1A deficiency enhanced pre-osteoblast proliferation but impaired mineralization under osteoporotic conditions.
- * BMPR1A deficiency triggered mTOR-autophagy pathway perturbation, enhancing transient proliferation but hindering final mineralization.
Conclusions:
- * BMPR1A acts as a double-edged sword in osteoporotic bone formation.
- * The BMPR1A-mTOR/autophagy axis is significant in regulating osteoblast function during osteoporosis.
- * This study provides novel insights for developing therapeutic strategies for osteoporosis.
More Related Videos
09:37A RANKL-based Osteoclast Culture Assay of Mouse Bone Marrow to Investigate the Role of mTORC1 in Osteoclast Formation
Published on: March 15, 2018
06:00Development of a Human Preclinical Model of Osteoclastogenesis from Peripheral Blood Monocytes Co-cultured with Breast Cancer Cell Lines
Published on: September 13, 2017
Related Concept Videos
Osteoclasts in Bone Remodeling
Bone Remodeling
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Bone Disorders
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
PI3K/mTOR/AKT Signaling Pathway
Autophagy
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...